DMK Pharmaceuticals Corporation (DMKPQ)
OTCMKTS: DMKPQ · Delayed Price · USD
0.0260
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
DMK Pharmaceuticals Market Cap
DMK Pharmaceuticals has a market cap or net worth of $262.65 thousand as of July 22, 2024. Its market cap has decreased by -99.12% in one year.
Market Cap
262.65K
Enterprise Value
-6.34M
1-Year Change
-99.12%
Ranking
n/a
Category
Stock Price
$0.03
Market Cap Chart
Since December 1, 1998, DMK Pharmaceuticals's market cap has decreased from $43.20M to $262.65K, a decrease of -99.39%. That is a compound annual growth rate of -18.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 6, 2024 | 2.30M | -67.61% |
Dec 29, 2023 | 7.10M | -72.05% |
Dec 30, 2022 | 25.40M | -71.81% |
Dec 31, 2021 | 90.10M | 98.46% |
Dec 31, 2020 | 45.40M | 5.09% |
Dec 31, 2019 | 43.20M | -59.40% |
Dec 31, 2018 | 106.40M | -27.57% |
Dec 29, 2017 | 146.90M | 116.03% |
Dec 30, 2016 | 68.00M | -6.21% |
Dec 31, 2015 | 72.50M | 11.37% |
Dec 31, 2014 | 65.10M | 65.23% |
Dec 31, 2013 | 39.40M | -43.95% |
Dec 31, 2012 | 70.30M | 344.94% |
Dec 30, 2011 | 15.80M | -14.13% |
Dec 31, 2010 | 18.40M | 26.90% |
Dec 31, 2009 | 14.50M | 1,108.33% |
Dec 31, 2008 | 1.20M | -20.00% |
Dec 31, 2007 | 1.50M | -16.67% |
Dec 29, 2006 | 1.80M | -89.22% |
Dec 30, 2005 | 16.70M | -77.64% |
Dec 31, 2004 | 74.70M | 20.10% |
Dec 31, 2003 | 62.20M | -21.27% |
Dec 31, 2002 | 79.00M | -44.72% |
Dec 31, 2001 | 142.90M | 76.64% |
Dec 29, 2000 | 80.90M | 100.74% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 814.94B |
Novo Nordisk | 579.91B |
UnitedHealth Group | 520.32B |
Johnson & Johnson | 372.29B |
Merck & Co. | 318.55B |
AbbVie | 304.29B |
AstraZeneca | 244.04B |
Novartis AG | 207.64B |